Although some studies showed a trend towards decreased disease-free survival in patients with advanced HCC (based on size and number) compared to those with less advanced HCC before downstaging, none reached significance [ 5 , 8 , 20 ].
← all excerpts
European Society of Organ Transplantation (ESOT) Consensus Report on Downstaging, Bridging and Immunotherapy in Liver Transplantation for Hepatocellular Carcinoma.
1
—
—